Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | EGFR | P00533 | 4/20 | 0.33 |
| ▸ | ERBB3 | P21860 | 2/20 | 0.33 |
| ▸ | SSTR4 | P31391 | 2/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | BTK | Q06187 | 2/20 | 0.32 |
| ▸ | KDM5A | P29375 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26120703 | 0.80 | EGFR (0.34) | MAPK1EGFRERBB3KDM5A | |
| SCHEMBL26125195 | 0.80 | MAPK1 (0.33) | MAPK1EGFRERBB3SSTR4KDM5A | |
| SCHEMBL25263633 | 0.75 | KLKB1 (0.35) | — | |
| SCHEMBL26123856 | 0.74 | MAP3K12 (0.34) | — | |
| SCHEMBL26121851 | 0.72 | CHRNB2 (0.49) | — | |
| SCHEMBL26125262 | 0.72 | CHRNB2 (0.49) | — | |
| SCHEMBL30937244 | 0.71 | LPO (0.38) | L3MBTL1P2RX7ALDH1A1TSHRKMT2A | |
| SCHEMBL30782144 | 0.67 | LPO (0.34) | L3MBTL1P2RX7 | |
| SCHEMBL26545651 | 0.67 | LPO (0.34) | — | |
| SCHEMBL26123651 | 0.63 | CHRNB2 (0.42) | MAPK1KDM5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023192960-A1 | STAT MODULATORS AND USES THEREOF | RECLUDIX PHARMA, INC. (US) | 2023-10-05 | — | — | WO | disclosed |